Treatment

Advanced Liver Disease and Hepatocellular Carcinoma Linked to Higher Mortality With Hepatitis C

Failure to achieve sustained virological response (SVR) and the presence of advanced liver disease are linked to higher mortality in patients with hepatitis C (HCV)…

Jennifer Geremia,

MSPAS, PA-C
Physician Associate, Brigham and Women's Hospital & Teaching Hospital of Harvard Medical School

Patient Management Guidelines

Articles

Patients With Hemodialysis: Calls for Better Prevention

A study aimed to determine the prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus...

CURATED BY:
Geraldine Joseph,
MPH, RPA-C, AAHIVM

Modern Antiviral Treatments for HCV Achieve More Than 98% Cure Rates

Decades ago, in the 1970s, cases of transfusion-associated hepatitis, called non-A, non-B hepatitis (NANBH), were often chronic, but the cause...

CURATED BY:
Gabriella McCarty,
MSN, NP-C

UK’s 2030 Hepatitis Elimination Strategy

Hepatitis B and C viruses remain leading causes of disability and premature death worldwide. In May 2016, the UK adopted...

CURATED BY:
Gabriella McCarty,
MSN, NP-C

How Prevalent Is the Hepatitis C Virus?

A recent systematic review and meta-analysis aimed to estimate the global prevalence of hepatitis C virus (HCV) among dialysis patients...

CURATED BY:
Geraldine Joseph,
MPH, RPA-C, AAHIVM

HCV-Related Arthropathy: Common, Benign, and Crucial for Early Detection

Hepatitis C (HCV) can cause kidney injury through immune complexes, cryoglobulins, and direct viral effects, leading to acute kidney injury...

CURATED BY:
Geraldine Joseph,
MPH, RPA-C, AAHIVM

Direct-Acting Antivirals Allow HCV Treatment for Substance Users Without Abstinence

Substance use disorders affect roughly 25% of Americans aged 12 and older, with illicit drug use prevalent in 2022. The...

CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Company
Contact

Partner with Us
Ambassador Program

Treatment

Advanced Liver Disease and Hepatocellular Carcinoma Linked to Higher Mortality With Hepatitis C

Jennifer Geremia,

Patient Management Guidelines

Articles

Patients With Hemodialysis: Calls for Better Prevention

Modern Antiviral Treatments for HCV Achieve More Than 98% Cure Rates

UK’s 2030 Hepatitis Elimination Strategy

How Prevalent Is the Hepatitis C Virus?

HCV-Related Arthropathy: Common, Benign, and Crucial for Early Detection

Direct-Acting Antivirals Allow HCV Treatment for Substance Users Without Abstinence

© 2024 Point of Care Network, LLC. All Rights Reserved.

© 2024 Point of Care Network, LLC. All Rights Reserved.

Share